Swiss Re stock holds USD 4.5 billion target after profit rise
Published on 11/12/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSwiss Re earnings and outlook
- Nine-month net income rose 3% to USD 4.2 billion, while return on equity held at 22.5%.
- Life and Health Reinsurance profit increased 43% to USD 1.5 billion and offset weaker Property and Casualty Reinsurance earnings.
- Management kept the 2026 group net income target at USD 4.5 billion despite competitive pricing conditions.
Swiss Re reported net income of USD 4.2 billion for the first nine months of 2026, up 3% from the same period last year. The Zurich-based reinsurer kept its full-year group net income target at USD 4.5 billion, according to the Swiss Re press release published on Thursday, November 5, 2026.
Diversification supports group earnings
Return on equity remained at 22.5%, matching the prior-year period. The insurance service result, which reflects underwriting profit earned during the period, rose to USD 5.1 billion from USD 4.8 billion. Group insurance revenue declined to USD 31.2 billion from USD 32.0 billion, while the new business contractual service margin fell to USD 2.8 billion from USD 3.9 billion.
Life and Health Reinsurance provided the strongest earnings lift. Its net income rose 43% to USD 1.5 billion from USD 1.1 billion, supported by a large in-force portfolio and favorable US mortality experience. The unit is targeting USD 1.7 billion in net income for the full year.
Property and Casualty Reinsurance generated USD 2.2 billion in net income, down 6% from USD 2.3 billion. Swiss Re attributed the decline to competitive market conditions. The unit's combined ratio improved to 77.3% from 77.6%, below its full-year target of less than 85%, while insurance revenue fell to USD 12.8 billion from USD 14.0 billion.
Capital strength and cost focus
Corporate Solutions increased net income 3% to USD 714 million and improved its combined ratio to 86.4% from 87.1%. The division also announced a strategic cooperation with Old Mutual Insure in South Africa, subject to regulatory approval, as part of its expansion through local partnerships.
Swiss Re said its estimated Group Swiss Solvency Test ratio stood at 259% on October 1, 2026, above the target range of 200% to 250%. The company also said its USD 1.5 billion share buyback programme, announced in February, was nearly complete. It continues to target USD 500 million in operating cost reductions by 2028.
Competitive pricing stays in focus
Chief Executive Officer Andreas Berger said disciplined underwriting and portfolio diversification put the group on track to meet its financial and resilience goals. Chief Financial Officer Anders Malmstrom highlighted lower margins on new business in the competitive property and casualty market, while citing recurring investment income and Life and Health earnings as support for profitability.
Swiss Re stock traded at EUR 161.90 on Lang & Schwarz at 11:01 CET on Thursday, November 12, 2026. The next scheduled corporate milestone is the presentation of 2027 financial targets on December 4, 2026, followed by full-year 2026 results on February 26, 2027.
The broader Swiss market remains relevant for Swiss Re investors through the SMI.
For continuing company coverage, see More news and analyses on Swiss Re stock.
Swiss Re at a glance
- Company: Swiss Re AG
- ISIN: CH0126881561
- WKN: A1H81M
- Symbol: SR9
- Trading venue: Lang & Schwarz
- Price: EUR 161.90 at 11:01 CET on November 12, 2026
